These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 14604653)
1. Synthesis and beta-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]pyridine: identification of beta 3-antagonists. Saccomanni G; Badawneh M; Adinolfi B; Calderone V; Cavallini T; Ferrarini PL; Greco R; Manera C; Testai L Bioorg Med Chem; 2003 Nov; 11(23):4921-31. PubMed ID: 14604653 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and beta-blocking activity of (R,S)-(E)-oximeethers of 2, 3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2, 3-b]pyridine:potential antihypertensive agents - part IX. Ferrarini PL; Mori C; Badawneh M; Calderone V; Greco R; Manera C; Martinelli A; Nieri P; Saccomanni G Eur J Med Chem; 2000 Sep; 35(9):815-26. PubMed ID: 11006483 [TBL] [Abstract][Full Text] [Related]
4. Antilipolytic effects of 1,8-naphthyridine derivatives β-adrenoceptor antagonists in rat white adipocytes. Aljamal JA; Badawneh M Chem Biol Drug Des; 2017 Jul; 90(1):119-127. PubMed ID: 28054456 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the biochemical effects of new 1, 8-naphthyridine derivatives, beta-receptor antagonists, in ventricular myocytes. Al jamal JA; Badawneh M Arch Pharm (Weinheim); 2003 Aug; 336(6-7):285-92. PubMed ID: 12953216 [TBL] [Abstract][Full Text] [Related]
6. Pyridine isosteres of the -adrenergic antagonists, 2-(p-nitrophenyl)-1-isopropylamino-2-ethanol and 3-(p-nitrophenoxy)-1-isopropylamino-2-propanol. Gnewuch CT; Friedman HL J Med Chem; 1972 Dec; 15(12):1321-4. PubMed ID: 4404591 [No Abstract] [Full Text] [Related]
7. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I). Khouili M; Guillaumet G; Coudert G; Pujol MD Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139 [TBL] [Abstract][Full Text] [Related]
8. Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivatives. Wang J; Breslin MJ; Coleman PJ; Duggan ME; Hunt CA; Hutchinson JH; Leu CT; Rodan SB; Rodan GA; Duong LT; Hartman GD Bioorg Med Chem Lett; 2004 Feb; 14(4):1049-52. PubMed ID: 15013021 [TBL] [Abstract][Full Text] [Related]
9. Structure-affinity relationships of 12-sulfonyl derivatives of 5,8,8a,9,10,11,12,12a,13,13a-decahydro-6H-isoquino[2,1-g][1 ,6] naphthyridines at alpha-adrenoceptors. Clark RD; Repke DB; Berger J; Nelson JT; Kilpatrick AT; Brown CM; MacKinnon AC; Clague RU; Spedding M J Med Chem; 1991 Feb; 34(2):705-17. PubMed ID: 1671705 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, docking study and β-adrenoceptor activity of some new oxime ether derivatives. Ghabbour HA; El-Bendary ER; El-Ashmawy MB; El-Kerdawy MM Molecules; 2014 Mar; 19(3):3417-35. PubMed ID: 24658567 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers. Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II). Khouili M; Guillaumet G; Coudert G; Pujol MD Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological activities of 1,8-naphthyridine derivatives. Leonard JT; Gangadhar R; Gnanasam SK; Ramachandran S; Saravanan M; Sridhar SK Biol Pharm Bull; 2002 Jun; 25(6):798-802. PubMed ID: 12081151 [TBL] [Abstract][Full Text] [Related]
14. A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives. Ferrarini PL; Mori C; Manera C; Martinelli A; Mori F; Saccomanni G; Barili PL; Betti L; Giannaccini G; Trincavelli L; Lucacchini A J Med Chem; 2000 Jul; 43(15):2814-23. PubMed ID: 10956189 [TBL] [Abstract][Full Text] [Related]